-
1
-
-
33745464490
-
Fluorinated pyrimidines, a new class of tumour-inhibitory compounds
-
Heidelberger C, Chaudhuri NK, Danneberg P, et al: Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 179: 663-666, 1957.
-
(1957)
Nature
, vol.179
, pp. 663-666
-
-
Heidelberger, C.1
Chaudhuri, N.K.2
Danneberg, P.3
-
2
-
-
13744251436
-
Systemic therapy for colorectal cancer
-
Meyerhardt JA and Mayer RJ: Systemic therapy for colorectal cancer. N Engl J Med 352: 476-487, 2005.
-
(2005)
N Engl J Med
, vol.352
, pp. 476-487
-
-
Meyerhardt, J.A.1
Mayer, R.J.2
-
3
-
-
0344109583
-
Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer
-
Meta-analysis Group In Cancer
-
Meta-analysis Group In Cancer: Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16: 301-308, 1998.
-
(1998)
J Clin Oncol
, vol.16
, pp. 301-308
-
-
-
4
-
-
14844303761
-
Capecitabine: A review
-
Walko CM and Lindley C: Capecitabine: a review. Clin Ther 27: 23-44, 2005.
-
(2005)
Clin Ther
, vol.27
, pp. 23-44
-
-
Walko, C.M.1
Lindley, C.2
-
5
-
-
0035503151
-
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study
-
Van Cutsem E, Twelves C, Cassidy J, et al: Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19: 4097-4106, 2001.
-
(2001)
J Clin Oncol
, vol.19
, pp. 4097-4106
-
-
Van Cutsem, E.1
Twelves, C.2
Cassidy, J.3
-
6
-
-
0035871538
-
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study
-
Hoff PM, Ansari R, Batist G, et al: Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 19: 2282-2292, 2001.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2282-2292
-
-
Hoff, P.M.1
Ansari, R.2
Batist, G.3
-
7
-
-
0030883708
-
Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin
-
Leichman CG, Lenz HJ, Leichman L, et al: Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol 15: 3223-3229, 1997.
-
(1997)
J Clin Oncol
, vol.15
, pp. 3223-3229
-
-
Leichman, C.G.1
Lenz, H.J.2
Leichman, L.3
-
8
-
-
0028097137
-
A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil
-
Beck A, Etienne MC, Cheradame S, Fischel JL, Formento P, Renee N and Milano G: A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. Eur J Cancer 30A: 1517-1522, 1994.
-
(1994)
Eur J Cancer
, vol.30 A
, pp. 1517-1522
-
-
Beck, A.1
Etienne, M.C.2
Cheradame, S.3
Fischel, J.L.4
Formento, P.5
Renee, N.6
Milano, G.7
-
9
-
-
0037312517
-
Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer
-
Ichikawa W, Uetake H, Shirota Y, et al: Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. Clin Cancer Res 9: 786-791, 2003.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 786-791
-
-
Ichikawa, W.1
Uetake, H.2
Shirota, Y.3
-
10
-
-
0028940399
-
Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors
-
Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV and Leichman L: Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 55: 1407-1412, 1995.
-
(1995)
Cancer Res
, vol.55
, pp. 1407-1412
-
-
Johnston, P.G.1
Lenz, H.J.2
Leichman, C.G.3
Danenberg, K.D.4
Allegra, C.J.5
Danenberg, P.V.6
Leichman, L.7
-
11
-
-
1442290323
-
Thymidylate synthase expression and prognosis in colorectal cancer: A systematic review and meta-analysis
-
Popat S, Matakidou A and Houlston RS: Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 22: 529-536, 2004.
-
(2004)
J Clin Oncol
, vol.22
, pp. 529-536
-
-
Popat, S.1
Matakidou, A.2
Houlston, R.S.3
-
12
-
-
0031722179
-
High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with non-response to 5-fluorouracil
-
Metzger R, Danenberg K, Leichman CG, et al: High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with non-response to 5-fluorouracil. Clin Cancer Res 4: 2371-2376, 1998.
-
(1998)
Clin Cancer Res
, vol.4
, pp. 2371-2376
-
-
Metzger, R.1
Danenberg, K.2
Leichman, C.G.3
-
13
-
-
0034048729
-
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase
-
Salonga D, Danenberg KD, Johnson M, et al: Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 6: 1322-1327, 2000.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 1322-1327
-
-
Salonga, D.1
Danenberg, K.D.2
Johnson, M.3
-
14
-
-
27644549567
-
Immunohistochemical expression of thymidylate synthase as predictor of response to capecitabine in patients with advanced colorectal adenocarcinoma
-
Lindebjerg J, Nielsen JN, Hoeffding LD and Jakobsen A: Immunohistochemical expression of thymidylate synthase as predictor of response to capecitabine in patients with advanced colorectal adenocarcinoma. APMIS 113: 600-602, 2005.
-
(2005)
APMIS
, vol.113
, pp. 600-602
-
-
Lindebjerg, J.1
Nielsen, J.N.2
Hoeffding, L.D.3
Jakobsen, A.4
-
15
-
-
0031944611
-
Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts
-
Sawada N, Ishikawa T, Fukase Y, Nishida M, Yoshikubo T and Ishitsuka H: Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by Taxol/Taxotere in human cancer xenografts. Clin Cancer Res 4: 1013-1019, 1998. (Pubitemid 28183404)
-
(1998)
Clinical Cancer Research
, vol.4
, Issue.4
, pp. 1013-1019
-
-
Sawada, N.1
Ishikawa, T.2
Fukase, Y.3
Nishida, M.4
Yoshikubo, T.5
Ishitsuka, H.6
-
16
-
-
0032695102
-
X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts
-
Sawada N, Ishikawa T, Sekiguchi F, Tanaka Y and Ishitsuka H: X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res 5: 2948-2953, 1999. (Pubitemid 29493974)
-
(1999)
Clinical Cancer Research
, vol.5
, Issue.10
, pp. 2948-2953
-
-
Sawada, N.1
Ishikawa, T.2
Sekiguchi, F.3
Tanaka, Y.4
Ishitsuka, H.5
-
17
-
-
0035342546
-
Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA
-
DOI 10.1002/ijc.1212
-
Morita T, Matsuzaki A and Tokue A: Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA. Int J Cancer 92: 451-456, 2001. (Pubitemid 32249725)
-
(2001)
International Journal of Cancer
, vol.92
, Issue.3
, pp. 451-456
-
-
Morita, T.1
Matsuzaki, A.2
Tokue, A.3
-
18
-
-
0030726659
-
Laser capture microdissection: Molecular analysis of tissue
-
DOI 10.1126/science.278.5342.1481
-
Bonner RF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S and Liotta LA: Laser capture microdissection: molecular analysis of tissue. Science 278: 1481-1483, 1997. (Pubitemid 27509824)
-
(1997)
Science
, vol.278
, Issue.5342
, pp. 1481-1491
-
-
Bonner, R.F.1
Emmert-Buck, M.2
Cole, K.3
Pohida, T.4
Chuaqui, R.5
Goldstein, S.6
Liotta, L.A.7
-
19
-
-
0034146097
-
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence
-
Lord RV, Salonga D, Danenberg KD, et al: Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg 4: 135-142, 2000.
-
(2000)
J Gastrointest Surg
, vol.4
, pp. 135-142
-
-
Lord, R.V.1
Salonga, D.2
Danenberg, K.D.3
-
20
-
-
0020343311
-
Maximally selected chi square statistics
-
Miller R and Siegmund D: Maximally selected Chi square statistics. Biometrics 38: 1011-1016, 1982. (Pubitemid 14272808)
-
(1982)
Biometrics
, vol.38
, Issue.4
, pp. 1011-1016
-
-
Miller, R.1
Siegmund, D.2
-
21
-
-
0020341898
-
Maximally selected Chi square statistics for small samples
-
Halpern J: Maximally selected Chi square statistics for small samples. Biometrics 38: 1017-1023, 1982.
-
(1982)
Biometrics
, vol.38
, pp. 1017-1023
-
-
Halpern, J.1
-
22
-
-
0023187085
-
Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile
-
Heggie GD, Sommadossi JP, Cross DS, Huster WJ and Diasio RB: Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res 47: 2203-2206, 1987. (Pubitemid 17074634)
-
(1987)
Cancer Research
, vol.47
, Issue.8
, pp. 2203-2206
-
-
Heggie, G.D.1
Sommadossi, J.-P.2
Cross, D.S.3
-
23
-
-
0036934486
-
Predicting 5-FU sensitivity using human colorectal cancer specimens: Comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU
-
Isshi K, Sakuyama T, Gen T, Nakamura Y, Kuroda T, Katuyama T and Maekawa Y: Predicting 5-FU sensitivity using human colorectal cancer specimens: comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU. Int J Clin Oncol 7: 335-342, 2002.
-
(2002)
Int J Clin Oncol
, vol.7
, pp. 335-342
-
-
Isshi, K.1
Sakuyama, T.2
Gen, T.3
Nakamura, Y.4
Kuroda, T.5
Katuyama, T.6
Maekawa, Y.7
-
24
-
-
9144264837
-
Tumor dihydropyrimidine dehydrogenase in stage II and II colorectal cancer: Low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone
-
Tsuji T, Sawai T, Takeshita H, et al: Tumor dihydropyrimidine dehydrogenase in stage II and II colorectal cancer: low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone. Cancer Lett 204: 97-104, 2004.
-
(2004)
Cancer Lett
, vol.204
, pp. 97-104
-
-
Tsuji, T.1
Sawai, T.2
Takeshita, H.3
-
25
-
-
0034844358
-
Role of thymidine phosphorylase in biomodulation of fluoropyrimidines
-
DOI 10.2174/1389201013378662
-
Morita T, Matsuzaki A, Suzuki K and Tokue A: Role of thymidine phosphorylase in biomodulation of fluoropyrimidines. Curr Pharm Biotechnol 2: 257-267, 2001. (Pubitemid 32798800)
-
(2001)
Current Pharmaceutical Biotechnology
, vol.2
, Issue.3
, pp. 257-267
-
-
Morita, T.1
Matsuzaki, A.2
Suzuki, K.3
Tokue, A.4
-
26
-
-
25444489871
-
Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III): Correlation with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant chemoradiotherapy
-
Jakob C, Liersch T, Meyer W, et al: Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III): correlation with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant chemoradiotherapy. Am J Surg Pathol 29: 1304-1309, 2005.
-
(2005)
Am J Surg Pathol
, vol.29
, pp. 1304-1309
-
-
Jakob, C.1
Liersch, T.2
Meyer, W.3
|